T1CARE: A Trial of a Novel Intervention to Address Social Determinants of Health in Young Adults With Type 1 Diabetes

T1CARE: A Randomized Trial of a Novel Intervention to Address Social Determinants of Health in Young Adults With Type 1 Diabetes

Randomized controlled trial with a wait list control arm. Participants will be randomized 1:1 to T1CARE or wait list usual care arm. Participants will be recruited from the Yale Adult and Pediatric Diabetes Centers. Patients assigned to T1CARE will receive support from a Community Health Navigator at Project Access-New Haven.

Primary Objective To determine whether the T1CARE intervention improves resolution of health-related social needs compared to usual care.

Secondary Objectives

1. To assess the feasibility and acceptability of the T1CARE intervention.
2. To evaluate the impact of T1CARE on patient-reported outcomes, including diabetes distress, illness intrusiveness, and quality of life.
3. To examine preliminary effects on clinical outcomes, particularly changes in HbA1c.

Inclusion Criteria:

• Type 1 Diabetes
• fluent in Spanish or English who reside in the greater New Haven area

Exclusion Criteria:

• cognitive impairment and otherwise unable to give written informed consent about participating in this study